Cargando…

The Median Effective Concentration (EC(50)) of Epidural Ropivacaine With Different Doses of Oxycodone During Limb Surgery in Elderly Patients

BACKGROUND: Oxycodone can be used both intravenously and epidurally in elderly patients because of its strong analgesic effect and more slight respiratory inhibition compared with other opioids at the same effect. In this study, we determined the median effective concentration (EC(50)) of epidural r...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Kai, Wang, Yu-long, Teng, Wen-bin, He, Rui, Li, Yu-hong, Huang, Su-qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814631/
https://www.ncbi.nlm.nih.gov/pubmed/35127764
http://dx.doi.org/10.3389/fmed.2021.808850
_version_ 1784645106457903104
author Xie, Kai
Wang, Yu-long
Teng, Wen-bin
He, Rui
Li, Yu-hong
Huang, Su-qin
author_facet Xie, Kai
Wang, Yu-long
Teng, Wen-bin
He, Rui
Li, Yu-hong
Huang, Su-qin
author_sort Xie, Kai
collection PubMed
description BACKGROUND: Oxycodone can be used both intravenously and epidurally in elderly patients because of its strong analgesic effect and more slight respiratory inhibition compared with other opioids at the same effect. In this study, we determined the median effective concentration (EC(50)) of epidural ropivacaine required for great saphenous vein surgery in elderly patients in order to describe its pharmacodynamic interaction with oxycodone. METHODS: One hundred forty-one elderly patients scheduled for high ligation and stripping of the great saphenous vein surgery were allocated into three groups in a randomized, double-blinded manner as follows: Q2.5 group (2.5 mg oxycodone), Q5.0 group (5.0 mg oxycodone), and C group (normal saline). Anesthesia, was achieved with epidural ropivacaine and oxycodone. The EC(50) of ropivacaine for surgery with different doses of oxycodone was adjusted by using an up-and-down sequential methods with an adjacent concentration gradient at a factor of 0.9 to inhibit analgesia. Anesthesia associated adverse events and recovery, characteristics were also recorded. RESULTS: The EC(50) of ropivacaine for the great saphenous vein surgery in elderly patients was 0.399% (95% CI, 0.371–0.430%) in the Q2.5 group, 0.396% (95% CI, 0.355–0.441%) in the Q5.0 group, and 0.487% (95% CI, 0.510–0.465%) in the C group, respectively (P < 0.05). Specially, the EC(50) of ropivacaine in the Q2.5 and Q5.0 groups was lower than that in the C group (P < 0.01), But the difference between the Q2.5 group and the Q5.0 group was not significant (P > 0.05). There was no significant difference in the Bromage score from the motor block examination, heart rate (HR) or mean arterial pressure (MAP) at each observation time point after epidural administration among the three groups (P > 0.05). No serious adverse reactions occurred in any of the three groups. CONCLUSION: Oxycodone combined with ropivacaine epidural anesthesia can reduce the EC(50) of ropivacaine required for elderly patients undergoing the great saphenous vein surgery. There was no significant difference in anesthesia associated adverse events among the three groups. The recommended dose of oxycodone is 2.5 mg.
format Online
Article
Text
id pubmed-8814631
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88146312022-02-05 The Median Effective Concentration (EC(50)) of Epidural Ropivacaine With Different Doses of Oxycodone During Limb Surgery in Elderly Patients Xie, Kai Wang, Yu-long Teng, Wen-bin He, Rui Li, Yu-hong Huang, Su-qin Front Med (Lausanne) Medicine BACKGROUND: Oxycodone can be used both intravenously and epidurally in elderly patients because of its strong analgesic effect and more slight respiratory inhibition compared with other opioids at the same effect. In this study, we determined the median effective concentration (EC(50)) of epidural ropivacaine required for great saphenous vein surgery in elderly patients in order to describe its pharmacodynamic interaction with oxycodone. METHODS: One hundred forty-one elderly patients scheduled for high ligation and stripping of the great saphenous vein surgery were allocated into three groups in a randomized, double-blinded manner as follows: Q2.5 group (2.5 mg oxycodone), Q5.0 group (5.0 mg oxycodone), and C group (normal saline). Anesthesia, was achieved with epidural ropivacaine and oxycodone. The EC(50) of ropivacaine for surgery with different doses of oxycodone was adjusted by using an up-and-down sequential methods with an adjacent concentration gradient at a factor of 0.9 to inhibit analgesia. Anesthesia associated adverse events and recovery, characteristics were also recorded. RESULTS: The EC(50) of ropivacaine for the great saphenous vein surgery in elderly patients was 0.399% (95% CI, 0.371–0.430%) in the Q2.5 group, 0.396% (95% CI, 0.355–0.441%) in the Q5.0 group, and 0.487% (95% CI, 0.510–0.465%) in the C group, respectively (P < 0.05). Specially, the EC(50) of ropivacaine in the Q2.5 and Q5.0 groups was lower than that in the C group (P < 0.01), But the difference between the Q2.5 group and the Q5.0 group was not significant (P > 0.05). There was no significant difference in the Bromage score from the motor block examination, heart rate (HR) or mean arterial pressure (MAP) at each observation time point after epidural administration among the three groups (P > 0.05). No serious adverse reactions occurred in any of the three groups. CONCLUSION: Oxycodone combined with ropivacaine epidural anesthesia can reduce the EC(50) of ropivacaine required for elderly patients undergoing the great saphenous vein surgery. There was no significant difference in anesthesia associated adverse events among the three groups. The recommended dose of oxycodone is 2.5 mg. Frontiers Media S.A. 2022-01-21 /pmc/articles/PMC8814631/ /pubmed/35127764 http://dx.doi.org/10.3389/fmed.2021.808850 Text en Copyright © 2022 Xie, Wang, Teng, He, Li and Huang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Xie, Kai
Wang, Yu-long
Teng, Wen-bin
He, Rui
Li, Yu-hong
Huang, Su-qin
The Median Effective Concentration (EC(50)) of Epidural Ropivacaine With Different Doses of Oxycodone During Limb Surgery in Elderly Patients
title The Median Effective Concentration (EC(50)) of Epidural Ropivacaine With Different Doses of Oxycodone During Limb Surgery in Elderly Patients
title_full The Median Effective Concentration (EC(50)) of Epidural Ropivacaine With Different Doses of Oxycodone During Limb Surgery in Elderly Patients
title_fullStr The Median Effective Concentration (EC(50)) of Epidural Ropivacaine With Different Doses of Oxycodone During Limb Surgery in Elderly Patients
title_full_unstemmed The Median Effective Concentration (EC(50)) of Epidural Ropivacaine With Different Doses of Oxycodone During Limb Surgery in Elderly Patients
title_short The Median Effective Concentration (EC(50)) of Epidural Ropivacaine With Different Doses of Oxycodone During Limb Surgery in Elderly Patients
title_sort median effective concentration (ec(50)) of epidural ropivacaine with different doses of oxycodone during limb surgery in elderly patients
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814631/
https://www.ncbi.nlm.nih.gov/pubmed/35127764
http://dx.doi.org/10.3389/fmed.2021.808850
work_keys_str_mv AT xiekai themedianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients
AT wangyulong themedianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients
AT tengwenbin themedianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients
AT herui themedianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients
AT liyuhong themedianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients
AT huangsuqin themedianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients
AT xiekai medianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients
AT wangyulong medianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients
AT tengwenbin medianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients
AT herui medianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients
AT liyuhong medianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients
AT huangsuqin medianeffectiveconcentrationec50ofepiduralropivacainewithdifferentdosesofoxycodoneduringlimbsurgeryinelderlypatients